Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

Recommendation

Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases

Free

Online download statistics by month:

Online download statistics by month: September 2017 to August 2020

	Abstract	Full	Pdf
Sep 2017	7389	900	680
Oct 2017	3870	391	347
Nov 2017	2902	222	179
Dec 2017	1590	82	104
Jan 2018	2515	418	343
Feb 2018	1491	282	260
Mar 2018	1190	152	91
Apr 2018	749	118	68
May 2018	761	65	64
Jun 2018	552	59	31
Jul 2018	476	45	39
Aug 2018	367	49	37
Sep 2018	427	49	38
Oct 2018	543	60	60
Nov 2018	506	66	55
Dec 2018	370	40	36
Jan 2019	429	66	51
Feb 2019	400	47	37
Mar 2019	489	75	63
Apr 2019	393	59	48
May 2019	398	52	35
Jun 2019	356	39	25
Jul 2019	351	37	35
Aug 2019	259	25	14
Sep 2019	324	25	18
Oct 2019	330	41	24
Nov 2019	298	37	31
Dec 2019	237	30	23
Jan 2020	252	31	14
Feb 2020	243	54	23
Mar 2020	289	48	28
Apr 2020	241	35	13
May 2020	240	42	13
Jun 2020	179	27	15
Jul 2020	121	116	51
Aug 2020	114	109	51
Total	31641	3993	3044